RIVM European Reference Lab for vector-borne infections The European Commission (EC) has designated RIVM as the current European Reference Lab (EURL) for vector-borne viral pathogens.
Menno de Jong appointed director of RIVM Centre for Infectious Disease Control Starting 1 May 2024, Professor Menno de Jong will take on the role of director of RIVM’s Centre for Infectious Disease Control (CIb) . He succeeds Jaap van Dissel, who is retiring in April 2024.
In 2023 more Dutch people play sports on a weekly basis In 2023, 56% of the Dutch population aged four and over played sports at least once a week. This figure marks an increase from 53% in 2022. Notably, the percentage of individuals with physical disabilities who played sports weekly saw a significant rise, from 23% to 29%.
Number of Combined Lifestyle Intervention participants more than doubles in one year The number of participants that has started the Combined Lifestyle Intervention (CLI) has more than doubled over the course of a single year. Nationwide, over 82,000 people have now started the CLI. According to RIVM’s annual report, most of the participants achieve a good outcome.
Predicting who will experience symptoms after Lyme disease remains challenging Each year, approximately 27,000 people are diagnosed with Lyme disease. For most, the symptoms disappear after treatment with antibiotics. Unfortunately, 25% of those treated have chronic symptoms, such as fatigue, concentration disorders or pain.
Adherence to Physical Activity Guidelines particularly low among young adults The number of people in the Netherlands aged four and over who meet the Physical Activity Guidelines has fallen since 2020. In 2022, 44.3% of the population was sufficiently physically active.
Respiratory infections now in season More and more people are coughing and sneezing, although it is not an epidemic at this point. The season in which respiratory infections circulate in the Netherlands has now started. There are various viruses that can cause respiratory infections.
Flu vaccine campaign about to start In October, many people will receive a new invitation to get the flu vaccine. The flu vaccine protects people who, because of their age or medical condition, are more likely to become ill or seriously ill from flu.
COVID-19 vaccination for risk groups: over-60s, flu vaccine group, care workers and pregnant women From 19 September 2023 on, the first people will receive an invitation for COVID-19 vaccination. The first invitations will be sent by RIVM to people aged 60 years and older.
Number of Lyme disease diagnoses remains high In 2021, the number of Lyme disease diagnoses with a red ring or rash– known as an erythema migrans, or EM – remained as high as in the previous survey in 2017. GPs diagnosed 25,600 patients with a red ring or rash caused by the Lyme bacteria.